VFA
ASMB icon

Valeo Financial Advisors’s Assembly Biosciences ASMB Stock Holding History

Valeo Financial Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-83
Closed -$3K – 599
2021
Q3 		$3K Sell
83
-209
-72% -$8.76K ﹤0.01% 581
2021
Q2 		$14K Buy
292
+159
+120% +$7.88K ﹤0.01% 508
2021
Q1 		$7K Buy
133
+83
+166% +$5.5K ﹤0.01% 1438
2020
Q4 		$4K Buy
+50
New +$5.87K ﹤0.01% 1396

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Valeo Financial Advisors's ASMB Position: Q1 2022 in Review

Valeo Financial Advisors sold out of Assembly Biosciences (ASMB) in Q1 2022, closing a stake of 2,125 shares — an estimated $59K sold.

Valeo Financial Advisors first reported a position in ASMB in Q3 2017 and held it in 16 quarters. The position peaked at $4.96M in Q3 2017. 54 funds tracked by Wall St. Rank hold ASMB as of Q1 2022.

  • Valeo Financial Advisors reported no remaining Assembly Biosciences position as of Q1 2022 after selling out during the quarter.
  • Valeo Financial Advisors sold 2,125 Assembly Biosciences shares in Q1 2022, an estimated $59K.
  • Valeo Financial Advisors first reported a position in Assembly Biosciences in Q3 2017 and held it in 16 quarters.
  • Valeo Financial Advisors's Assembly Biosciences position peaked at $4.96M in Q3 2017.
  • 54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2022.

Based on Valeo Financial Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.